[PHARMA] YoY Cumulative Quarter Result on 31-Mar-2011 [#1]

Announcement Date
13-May-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2011
Quarter
31-Mar-2011 [#1]
Profit Trend
QoQ- -49.04%
YoY- 66.37%
Quarter Report
View:
Show?
Cumulative Result
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
Revenue 468,672 500,339 446,745 385,328 317,560 313,716 309,650 7.14%
PBT 38,159 36,924 42,955 21,792 12,431 20,184 27,374 5.68%
Tax -11,513 -11,771 -13,894 -6,193 -3,122 -5,491 -8,392 5.40%
NP 26,646 25,153 29,061 15,599 9,309 14,693 18,982 5.81%
-
NP to SH 26,217 24,771 28,685 15,484 9,307 14,522 18,545 5.93%
-
Tax Rate 30.17% 31.88% 32.35% 28.42% 25.11% 27.20% 30.66% -
Total Cost 442,026 475,186 417,684 369,729 308,251 299,023 290,668 7.23%
-
Net Worth 515,022 484,829 474,161 437,661 439,675 402,378 367,905 5.76%
Dividend
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
Div 10,352 8,825 8,824 - - - - -
Div Payout % 39.49% 35.63% 30.76% - - - - -
Equity
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
Net Worth 515,022 484,829 474,161 437,661 439,675 402,378 367,905 5.76%
NOSH 258,805 117,676 117,657 107,007 106,977 107,015 106,949 15.86%
Ratio Analysis
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
NP Margin 5.69% 5.03% 6.51% 4.05% 2.93% 4.68% 6.13% -
ROE 5.09% 5.11% 6.05% 3.54% 2.12% 3.61% 5.04% -
Per Share
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
RPS 181.09 425.18 379.70 360.09 296.85 293.15 289.53 -7.51%
EPS 10.13 21.05 24.38 14.47 8.70 13.57 17.34 -8.56%
DPS 4.00 7.50 7.50 0.00 0.00 0.00 0.00 -
NAPS 1.99 4.12 4.03 4.09 4.11 3.76 3.44 -8.71%
Adjusted Per Share Value based on latest NOSH - 107,007
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
RPS 32.52 34.72 31.00 26.74 22.03 21.77 21.48 7.15%
EPS 1.82 1.72 1.99 1.07 0.65 1.01 1.29 5.90%
DPS 0.72 0.61 0.61 0.00 0.00 0.00 0.00 -
NAPS 0.3573 0.3364 0.329 0.3037 0.3051 0.2792 0.2553 5.75%
Price Multiplier on Financial Quarter End Date
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
Date 31/03/14 29/03/13 30/03/12 31/03/11 31/03/10 31/03/09 31/03/08 -
Price 4.46 8.26 5.90 5.73 4.27 3.45 2.95 -
P/RPS 2.46 1.94 1.55 1.59 1.44 1.18 1.02 15.79%
P/EPS 44.03 39.24 24.20 39.60 49.08 25.42 17.01 17.16%
EY 2.27 2.55 4.13 2.53 2.04 3.93 5.88 -14.66%
DY 0.90 0.91 1.27 0.00 0.00 0.00 0.00 -
P/NAPS 2.24 2.00 1.46 1.40 1.04 0.92 0.86 17.28%
Price Multiplier on Announcement Date
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
Date 14/05/14 15/05/13 03/05/12 13/05/11 26/05/10 08/05/09 28/05/08 -
Price 4.70 9.26 5.90 5.05 4.71 3.82 3.45 -
P/RPS 2.60 2.18 1.55 1.40 1.59 1.30 1.19 13.90%
P/EPS 46.40 43.99 24.20 34.90 54.14 28.15 19.90 15.14%
EY 2.16 2.27 4.13 2.87 1.85 3.55 5.03 -13.13%
DY 0.85 0.81 1.27 0.00 0.00 0.00 0.00 -
P/NAPS 2.36 2.25 1.46 1.23 1.15 1.02 1.00 15.37%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment